Researcher Leads Development of Urine Test for Prostate Cancer Detection
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read MorePosted by Andy Lundin | Aug 8, 2023 | Prostate |
Biomarkers of significant prostate cancer that are detected in urine or blood tests are desperately needed to help reduce prostate biopsies.
Read MorePosted by Andy Lundin | Jul 18, 2023 | Prostate |
Quest launched a prostate cancer biomarker test through its pathology business, AmeriPath, in collaboration with Envision Sciences.
Read MorePosted by Melanie Hamilton-Basich | Jul 7, 2023 | Prostate |
The AI-based predictive model was able to identify patients with a predominantly intermediate risk for prostate cancer likely to benefit from short-term ADT.
Read MorePosted by Melanie Hamilton-Basich | Jun 9, 2023 | Prostate |
American Indian and Alaska Native men also experience disproportionately greater prostate cancer mortality compared to other racial/ethnic identities.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Prostate |
The accuracy of PSA in prostate cancer screening can be improved by accounting for genetic factors that are not associated with cancer.
Read More